Upgrade to SI Premium - Free Trial

Alnylam Pharmaceuticals (ALNY) PT Lowered to $135 at Needham & Company

November 7, 2018 1:35 PM
Needham & Company analyst Alan Carr lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $135.00 (from $152.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles